SEALSQ Insider Trades
NASDAQ: LAESTechnologySemiconductorsUSD
Market open · Delayed 15 min · as of Oct 9, 2:41 PM ET
Last 12 months
- Purchases
- 0 · $0
- Sales
- 38 · $1.12M
- Shares bought / sold
- 0 / 397.11K
- Net activity
- Net selling $1.1 million
SEALSQ insider activity
Over the last 12 months, SEALSQ insiders reported 52 transactions on SEC Form 4: 0 open-market purchases and 38 sales. Insiders bought $0 and sold $1.1 million worth of stock, for net insider selling of $1.1 million. The largest seller was O'Hara John Charles, with $556,881 in reported sales.
The most recent filing shows Enguent Jean-Pierre (Vice President, R&DSS) selling 35,000 shares at $2.46 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LAES's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LAES insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | Enguent Jean-PierreVice President, R&DSS | Sale | 35,000 | $85.94K | Form 4 |
| Oct 5, 2026 | Enguent Jean-PierreVice President, R&DSS | Option exercise | 35,000 | $350 | Form 4 |
| Sep 3, 2026 | Enguent Jean-PierreVice President, R&DSS | Sale | 15,000 | $36.03K | Form 4 |
| Sep 1, 2026 | Enguent Jean-PierreVice President, R&DSS | Option exercise | 15,000 | $150 | Form 4 |
| Aug 5, 2026 | Enguent Jean-PierreVice President, R&DSS | Sale | 15,000 | $36.86K | Form 4 |
| Aug 3, 2026 | Enguent Jean-PierreVice President, R&DSS | Option exercise | 15,000 | $150 | Form 4 |
| Jul 8, 2026 | Enguent Jean-PierreVice President, R&DSS | Sale | 15,000 | $42.27K | Form 4 |
| Jul 6, 2026 | Enguent Jean-PierreVice President, R&DSS | Option exercise | 15,000 | $150 | Form 4 |
| Jun 16, 2026 | Ward PeterDirector | Tax withholding | 96,530 | $296.35K | Form 4 |
| Jun 16, 2026 | Ward PeterDirector | Option exercise | 366,746 | $3.67K | Form 4 |
| Jun 5, 2026 | Moreira CarlosChief Executive Officer | Sale | 300 | $1.05K | Form 4 |
| Jun 5, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 143 | $501.93 | Form 4 |
| Jun 3, 2026 | Enguent Jean-PierreVice President, R&DSS | Sale | 15,000 | $52.65K | Form 4 |
| Jun 3, 2026 | Moreira CarlosChief Executive Officer | Sale | 7,005 | $24.74K | Form 4 |
| Jun 3, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 5,582 | $19.70K | Form 4 |
| Jun 2, 2026 | Moreira CarlosChief Executive Officer | Sale | 10,000 | $36.91K | Form 4 |
| Jun 2, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $36.93K | Form 4 |
| Jun 1, 2026 | Enguent Jean-PierreVice President, R&DSS | Option exercise | 15,000 | $150 | Form 4 |
| May 29, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $35.08K | Form 4 |
| May 29, 2026 | Moreira CarlosChief Executive Officer | Sale | 10,000 | $35.09K | Form 4 |
| May 27, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 4,689 | $16.43K | Form 4 |
| May 27, 2026 | Moreira CarlosChief Executive Officer | Sale | 4,139 | $14.50K | Form 4 |
| May 14, 2026 | Buonanno Franck JeanVice-President, Global Sales | Sale | 20,000 | $58.00K | Form 4 |
| May 11, 2026 | Buonanno Franck JeanVice-President, Global Sales | Option exercise | 20,000 | $200 | Form 4 |
| May 6, 2026 | Enguent Jean-PierreVice President, R&DSS | Sale | 15,000 | $47.00K | Form 4 |
| May 4, 2026 | Enguent Jean-PierreVice President, R&DSS | Option exercise | 15,000 | $150 | Form 4 |
| Apr 24, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 5,250 | $15.26K | Form 4 |
| Apr 23, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $28.80K | Form 4 |
| Apr 22, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $30.56K | Form 4 |
| Apr 21, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $30.38K | Form 4 |
| Apr 20, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $27.88K | Form 4 |
| Apr 17, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $27.21K | Form 4 |
| Apr 16, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $26.95K | Form 4 |
| Apr 13, 2026 | O'Hara John CharlesChief Financial Officer | Option exercise | 130,500 | $1.30K | Form 4 |
| Apr 9, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $20.82K | Form 4 |
| Apr 8, 2026 | Enguent Jean-PierreVice President, R&DSS | Sale | 15,000 | $32.98K | Form 4 |
| Apr 8, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $21.98K | Form 4 |
| Apr 7, 2026 | Feuardent Moreira AndreasChief Innovation Officer | Sale | 10,000 | $23.10K | Form 4 |
| Apr 7, 2026 | Feuardent Moreira AndreasChief Innovation Officer | Option exercise | 10,000 | $100 | Form 4 |
| Apr 7, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $21.38K | Form 4 |
| Apr 6, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $24.17K | Form 4 |
| Apr 6, 2026 | Enguent Jean-PierreVice President, R&DSS | Option exercise | 15,000 | $150 | Form 4 |
| Apr 2, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $24.53K | Form 4 |
| Mar 31, 2026 | Buonanno Franck JeanVice-President, Global Sales | Sale | 10,000 | $23.50K | Form 4 |
| Mar 30, 2026 | O'Hara John CharlesChief Financial Officer | Option exercise | 100,000 | $1.00K | Form 4 |
| Mar 27, 2026 | Buonanno Franck JeanVice-President, Global Sales | Option exercise | 15,000 | $150 | Form 4 |
| Mar 25, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $29.25K | Form 4 |
| Mar 24, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $29.00K | Form 4 |
| Mar 23, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $29.89K | Form 4 |
| Mar 20, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $29.99K | Form 4 |
| Mar 19, 2026 | O'Hara John CharlesChief Financial Officer | Sale | 10,000 | $30.19K | Form 4 |
| Mar 18, 2026 | Verjus Nathalie Claude OdileCompany Secretary | Sale | 5,000 | $15.13K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4